The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 29, 2017
Filed:
Apr. 12, 2013
Applicants:
Phi Nguyen, Houston, TX (US);
Loc Phan, San Jose, CA (US);
Bao Tran, Saratoga, CA (US);
Thuan Nguyen, Houston, CA (US);
Duy Bui, Ha Noi, VN;
Inventors:
Phi Nguyen, Houston, TX (US);
Loc Phan, San Jose, CA (US);
Bao Tran, Saratoga, CA (US);
Thuan Nguyen, Houston, CA (US);
Duy Bui, Ha Noi, VN;
Assignee:
Other;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61L 27/20 (2006.01); A61L 27/16 (2006.01); A61L 27/50 (2006.01); A61L 27/52 (2006.01); A61L 27/54 (2006.01); A61F 2/12 (2006.01); A61L 27/22 (2006.01); A61F 2/00 (2006.01); A61L 27/36 (2006.01); A61L 27/58 (2006.01);
U.S. Cl.
CPC ...
A61L 27/20 (2013.01); A61F 2/0059 (2013.01); A61F 2/12 (2013.01); A61L 27/16 (2013.01); A61L 27/222 (2013.01); A61L 27/36 (2013.01); A61L 27/50 (2013.01); A61L 27/502 (2013.01); A61L 27/52 (2013.01); A61L 27/54 (2013.01); A61L 27/58 (2013.01); A61F 2230/0071 (2013.01); A61F 2250/0003 (2013.01); A61L 2300/204 (2013.01); A61L 2300/222 (2013.01); A61L 2300/402 (2013.01); A61L 2300/416 (2013.01); A61L 2400/06 (2013.01); A61L 2400/18 (2013.01); A61L 2430/04 (2013.01); A61L 2430/34 (2013.01);
Abstract
Systems and methods are disclosed for cosmetic augmentation by forming a biocompatible cross-linked polymer having a multi-phase mixture with a time release catalyst; injecting the mixture into a patient as a viscous fluid; after injection, activating the catalyst to cross-link the polymer after a predetermined period after injection into a patient; and augmenting soft tissue with the biocompatible cross-linked polymer.